---
title: "Canopus released its 2024 annual performance, with a net profit attributable to the parent company of 97.4248 million yuan, a year-on-year increase of 0.21%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235817008.md"
description: "Canopus released its 2024 annual report, with operating revenue of 435 million yuan, a year-on-year increase of 0.40%; net profit attributable to the parent company was 97.4248 million yuan, a year-on-year increase of 0.21%. The net profit excluding non-recurring gains and losses was 66.4591 million yuan, a year-on-year decrease of 2.49%. The basic earnings per share were 0.98 yuan, and it is proposed to distribute a cash dividend of 6 yuan for every 10 shares. The sales revenue of electric endoscopic stapler products increased by 131.92% year-on-year, becoming a new growth point for performance"
datetime: "2025-04-14T08:11:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235817008.md)
  - [en](https://longbridge.com/en/news/235817008.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235817008.md)
generator: "portal-rs"
---

# Canopus released its 2024 annual performance, with a net profit attributable to the parent company of 97.4248 million yuan, a year-on-year increase of 0.21%

According to the Zhitong Finance APP, Canopus (301290.SZ) released its annual report for 2024. During the reporting period, the company achieved an operating income of 435 million yuan, a year-on-year increase of 0.40%. The net profit attributable to shareholders of the listed company was 97.4248 million yuan, a year-on-year increase of 0.21%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 66.4591 million yuan, a year-on-year decrease of 2.49%. The basic earnings per share were 0.98 yuan. The company plans to distribute a cash dividend of 6 yuan (including tax) for every 10 shares to all shareholders.

During the reporting period, the company actively responded to market changes following the extensive implementation of the volume-based procurement policy and optimized its product structure. The sales revenue of the company's electric endoscope stapler products increased by 131.92% year-on-year, accounting for 25.79% of the operating income of stapler products in this period, becoming a new important growth point for the stapler business segment

### Related Stocks

- [301290.CN](https://longbridge.com/en/quote/301290.CN.md)

## Related News & Research

- [11:06 ETEndurance Named to Inc. 5000 for 11th Time, Continuing National Growth](https://longbridge.com/en/news/296124358.md)
- [Asker Healthcare Group buys Baltic medtech distributor Ambercell Solutions](https://longbridge.com/en/news/296306272.md)
- [Thales, Systematic partner to boost Danish air defense capabilities](https://longbridge.com/en/news/296363485.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)
- [XIAOMI-W Unveils New-Gen Humanoid Robot 'CyberOne'](https://longbridge.com/en/news/296450588.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**